Expanding the Inflation Reduction Act to Reduce Pharmaceutical Spending

This brief explores the current US standards for setting prescription drug prices and its implications along with plausible options to expand the Inflation Reduction Act to reduce pharmaceutical spending.

Published by   

Christopher Lee

   on   

April 7, 2026

Inquiry-driven, this project may reflect personal views, aiming to enrich problem-related discourse.

HeadingHeading 3

Card Title

Lorem ipsum dolor sit amet conse adipiscing elit

Card Title

Lorem ipsum dolor sit amet conse adipiscing elit

Card Title

Lorem ipsum dolor sit amet conse adipiscing elit

Card Title

Lorem ipsum dolor sit amet conse adipiscing elit

Support

No items found.